SPDR S&P Pharmaceuticals ETF (XPH) ETF
SPDR S&P Pharmaceuticals ETF (XPH) ETF Bio
The investment objective of the SPDR S&P Pharmaceuticals ETF is to provide investment results that correspond generally to the total return performance of the S&P Pharmaceuticals Select Industry Index.
XPH ETF Info
| Issuer | State Street Global Advisors |
| Expense Ratio | 0.35% |
| Underlying Index | S&P Pharmaceuticals Select Industry Index |
| Asset Class | Equity |
| Sector | Health & Biotech ETFs |
| Assets Under Management (AUM) | 228.82B |
| Net Asset Value (NAV) | $39.45 |
| Options? | Yes |
| Total Holdings | 43 |
XPH Stock Chart More Charts
XPH Price/Volume Stats
| Current price | $39.70 |
| Prev. close | $39.42 |
| Day low | $39.13 |
| Day high | $39.79 |
| 50-day MA | $41.30 |
| 200-day MA | $43.33 |
| 52-week high | $49.97 |
| 52-week low | $34.51 |
| Volume | 45,500 |
| Avg. volume | 62,739 |
| Dividend yield | 0.73% |
XPH Top Holdings
| Symbol | Company | % of Total |
| ZTS | Zoetis Inc. Class A | 5.12% |
| ELAN | Elanco Animal Health Inc. | 4.99% |
| PRGO | Perrigo Co. Plc | 4.94% |
| JNJ | Johnson & Johnson | 4.7% |
| MYL | Mylan N.V. | 4.63% |
| AGN | Allergan plc | 4.54% |
| JAZZ | Jazz Pharmaceuticals Plc | 4.54% |
| PFE | Pfizer Inc. | 4.47% |
| MRK | Merck & Co. Inc. | 4.33% |
| LLY | Eli Lilly and Company | 4.3% |
XPH Returns
| 1-mo | -2.93% |
| 3-mo | -0.11% |
| 6-mo | -7.03% |
| 1-year | -1.91% |
| 3-year | -7.10% |
| 5-year | -8.85% |
| YTD | 8.59% |
| 2018 | -15.32% |
| 2017 | 12.05% |
| 2016 | -23.20% |
| 2015 | -4.62% |
| 2014 | 29.52% |
XPH Dividends
| Ex-Dividend Date | Type | Payout Amount | Change | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||